Ariel Tarasiuk1, Tzahit Simon, Asher Tal, Haim Reuveni. 1. Sleep-Wake Disorders Unit, Soroka University Medical Center, and Department of Physiology, Beer-Sheva, Israel. arieltarasiuk@yahoo.com
Abstract
OBJECTIVE: To investigate health care utilization of children with obstructive sleep apnea syndrome (OSAS) 1 year after adenotonsillectomy (T&A). METHODS: A longitudinal, case-controlled, prospective study was conducted at Clalit Health Care Services (CHS), a health maintenance organization in the southern region of Israel. We defined 3 groups of children: 1) children who had OSAS and were treated with T&A (n = 130); 2) children who had OSAS and did not undergo surgery (n = 90); and 3) control subjects who were matched by age, sex, and area of residency (n = 520) and randomly selected from the CHS database. OSAS was verified with polysomnography studies in all patients. Indices of health care utilization were analyzed 1 year before and 1 year after T&A. Medical records in the emergency department and during hospitalization were reviewed for diagnosis before the polysomnography diagnosis. RESULTS: Mean age of all children with OSAS was 5.6 +/- 3.6 years. Total annual health care costs were reduced by one third in children who underwent T&A, whereas there was no change in the control and untreated OSAS groups. T&A was associated with a 60% reduction in the number of new admissions, 39% reduction in emergency department visits, 47% reduction in the number of consultations, and 22% reduction in costs for prescribed drugs. In group 2, the total costs were similar in years 1 and 2. CONCLUSIONS: T&A significantly reduces health care utilization in children with OSAS. Untreated children with moderate and severe OSAS will continue to consume high levels of health care resources. Increased morbidity among children with OSAS is mainly related to upper respiratory tract infections.
OBJECTIVE: To investigate health care utilization of children with obstructive sleep apnea syndrome (OSAS) 1 year after adenotonsillectomy (T&A). METHODS: A longitudinal, case-controlled, prospective study was conducted at Clalit Health Care Services (CHS), a health maintenance organization in the southern region of Israel. We defined 3 groups of children: 1) children who had OSAS and were treated with T&A (n = 130); 2) children who had OSAS and did not undergo surgery (n = 90); and 3) control subjects who were matched by age, sex, and area of residency (n = 520) and randomly selected from the CHS database. OSAS was verified with polysomnography studies in all patients. Indices of health care utilization were analyzed 1 year before and 1 year after T&A. Medical records in the emergency department and during hospitalization were reviewed for diagnosis before the polysomnography diagnosis. RESULTS: Mean age of all children with OSAS was 5.6 +/- 3.6 years. Total annual health care costs were reduced by one third in children who underwent T&A, whereas there was no change in the control and untreated OSAS groups. T&A was associated with a 60% reduction in the number of new admissions, 39% reduction in emergency department visits, 47% reduction in the number of consultations, and 22% reduction in costs for prescribed drugs. In group 2, the total costs were similar in years 1 and 2. CONCLUSIONS: T&A significantly reduces health care utilization in children with OSAS. Untreated children with moderate and severe OSAS will continue to consume high levels of health care resources. Increased morbidity among children with OSAS is mainly related to upper respiratory tract infections.
Authors: Roberto Hornero; Leila Kheirandish-Gozal; Gonzalo C Gutiérrez-Tobal; Mona F Philby; María Luz Alonso-Álvarez; Daniel Álvarez; Ehab A Dayyat; Zhifei Xu; Yu-Shu Huang; Maximiliano Tamae Kakazu; Albert M Li; Annelies Van Eyck; Pablo E Brockmann; Zarmina Ehsan; Narong Simakajornboon; Athanasios G Kaditis; Fernando Vaquerizo-Villar; Andrea Crespo Sedano; Oscar Sans Capdevila; Magnus von Lukowicz; Joaquín Terán-Santos; Félix Del Campo; Christian F Poets; Rosario Ferreira; Katalina Bertran; Yamei Zhang; John Schuen; Stijn Verhulst; David Gozal Journal: Am J Respir Crit Care Med Date: 2017-12-15 Impact factor: 21.405
Authors: Sivakumar Chinnadurai; Atia K Jordan; Nila A Sathe; Christopher Fonnesbeck; Melissa L McPheeters; David O Francis Journal: Pediatrics Date: 2017-01-17 Impact factor: 7.124